Intrinsic Value

Not Available for PLSE

There is not enough data to reliably calculate the intrinsic value for Pulse Biosciences Inc.

Do our valuations actually work? See backtest results .

Alternatives to PLSE

Fundamental Analysis

What Pulse Biosciences Does

Health Care

Pulse Biosciences develops medical technology that uses very short electrical pulses to destroy unwanted tissue without the heat and mechanical damage of traditional ablation tools. Its main product work centers on systems for treating skin conditions and other soft tissue targets, using a method the company calls nanosecond pulsed field ablation.

Headquarters
United States of America US
Employees
116
IPO date
May 18, 2016
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pulse Biosciences Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

PLSE Insider Trading
Buy and sell transactions by insiders